Acumen Net Invested Capital from 2010 to 2025
| ABOS Stock | USD 1.02 0.04 3.77% |
Net Invested Capital | First Reported 2010-12-31 | Previous Quarter 210.3 M | Current Value 162.9 M | Quarterly Volatility 112.3 M |
Check Acumen Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Acumen Pharmaceuticals' main balance sheet or income statement drivers, such as Net Interest Income of 10.8 M, Interest Income of 15 M or Depreciation And Amortization of 169.1 K, as well as many indicators such as Price To Sales Ratio of 415, Dividend Yield of 0.0 or PTB Ratio of 0.6. Acumen financial statements analysis is a perfect complement when working with Acumen Pharmaceuticals Valuation or Volatility modules.
Acumen | Net Invested Capital |
Latest Acumen Pharmaceuticals' Net Invested Capital Growth Pattern
Below is the plot of the Net Invested Capital of Acumen Pharmaceuticals over the last few years. It is the total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents. Acumen Pharmaceuticals' Net Invested Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Acumen Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Net Invested Capital | 10 Years Trend |
|
Net Invested Capital |
| Timeline |
Acumen Net Invested Capital Regression Statistics
| Arithmetic Mean | 59,289,856 | |
| Coefficient Of Variation | 189.38 | |
| Mean Deviation | 98,122,427 | |
| Median | (11,420,000) | |
| Standard Deviation | 112,283,372 | |
| Sample Variance | 12607.6T | |
| Range | 312.9M | |
| R-Value | 0.77 | |
| Mean Square Error | 5585.7T | |
| R-Squared | 0.59 | |
| Significance | 0.0005 | |
| Slope | 18,061,458 | |
| Total Sum of Squares | 189113.3T |
Acumen Net Invested Capital History
About Acumen Pharmaceuticals Financial Statements
Acumen Pharmaceuticals shareholders use historical fundamental indicators, such as Net Invested Capital, to determine how well the company is positioned to perform in the future. Although Acumen Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Acumen Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Acumen Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Invested Capital | 210.3 M | 162.9 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Acumen Stock Analysis
When running Acumen Pharmaceuticals' price analysis, check to measure Acumen Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acumen Pharmaceuticals is operating at the current time. Most of Acumen Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acumen Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acumen Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acumen Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.